OptimizeRx's market cap is currently $348.65M. The company's EPS TTM is $0.24; its P/E ratio is ―; OptimizeRx is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.
